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Background
Academic publishing depends, to a great extent, on
trust. Editors trust peer reviewers to provide fair
assessments, authors trust editors to select appropri-
ate peer reviewers, and readers put their trust in the
peer-review process. Academic publishing also occurs
in an environment of powerful intellectual, ﬁnancial,
and sometimes political interests that may collide or
compete. Good decisions and strong editorial proces-
ses designed to manage these interests will foster a
sustainable and efﬁcient publishing system, which
will beneﬁt academic societies, journal editors,
authors, research funders, readers, and publishers.
Good publication practices do not develop by
chance, and will become established only if they are
actively promoted.
These Best Practice Guidelines on Publication Ethics
have been written to offer journal editors a frame-
work for developing and implementing their own
publication ethics policies and systems. In some sec-
tors, notably medicine, the debate about publication
ethics is moving rapidly. In response, and at suitable
intervals, we will update our guidance. The general
principles of publication ethics are grouped and dis-
cussed under broad themes. Statements of principle
are followed by factors that may affect them. The
order of the sections does not imply a hierarchy of
importance.
Transparency
Who funded the work?
Readers have a right to know who funded a research
project or the publication of a document.
• Research funders should be listed on all research
papers.
• Funding for any type of publication, for example,
by a commercial company, charity or government
department, should be stated within the publication.
This applies to all types of papers (including, for
example, research papers, review papers, letters, edi-
torials, commentaries).
• The role of the research funder, as well as the
role of all parties contributing to the research and
publication, in designing the research, recruiting
investigators/authors, collecting the data, analyzing
the data, preparing the manuscript or controlling
publication decisions should be stated in the publica-
tion, unless this is obvious from the list of authors/
contributors.
• Other sources of support for publications should
be clearly identiﬁed in the manuscript, usually in an
acknowledgment. For example, these might include
funding for Blackwell Publishing OnlineOpen (open
access) publication, or funding for writing or editor-
ial assistance.
• See Box 1.
Who did the work?
The list of authors should accurately reﬂect who did
the work. All published work should be attributed to
one or more authors.
• Journal instructions for authors should explain
the concepts of academic authorship, setting out
which contributions do and do not qualify for
authorship.
• Journals should remind contributors about author-
ship guidelines [for example, the International
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criteria (1)] and should encourage their adher-
ence by appropriately designed authorship declara-
tions.
• Listing individuals’ contributions to the research
and publication process provides greater trans-
parency than the traditional listing of authors and
may discourage inappropriate authorship practices
such as ‘ghost’ authors (individuals who qualify for
authorship but are not listed) and ‘guest’ (or honor-
ary) authors (individuals who are listed despite not
qualifying for authorship, such as heads of depart-
ment not directly involved with research).
• Editors should ask for a declaration that all authors
meet the journal’s criteria for authorship and that
nobody who meets these criteria has been omitted
from the list.
• Editors should ask for a declaration that the
authors have acknowledged all signiﬁcant contribu-
tions made to their publication by individuals who
did not meet the journal’s criteria for authorship.
These might include, for example and depending on
their contribution, author’s editors, statisticians,
medical writers, or translators.
• If an authorship dispute or discrepancy comes to
light before publication (for example, changes to the
list of authors are proposed after submission), edi-
tors should take care to explain the journal’s author-
ship policy to the corresponding author and to
establish that all authors agree to the change before
proceeding with publication.
• If an authorship dispute emerges after publication
(for example, somebody contacts the editor claiming
they should have been an author of a published paper,
or requesting that their name be withdrawn from a
paper), the editor should contact the corresponding
author and, where possible, the other authors to estab-
lish the veracity of the case.
• If authorship policies have been clearly set out and
an explicit authorship declaration(s) has been
received (stating that all authors meet agreed criteria
and that nobody deserving authorship has been
omitted), then genuine errors are unlikely – however,
editors should consider publishing a correction in
the case of such errors.
• See Box 2, Box 3, Box 4.
• See Flowcharts 1a–d (pp. 13–15) ‘Changes in
authorship’ from Committee on Publication Ethics
(COPE).
Has the work been published before?
Most journals wish to consider only work that has not
been published elsewhere. One reason for this is that
the scientiﬁc literature can be skewed by redundant
publication, with important consequences, for exam-
ple, if results are inadvertently included more than
once into meta-analyses. Both journal editors and
readers have a right to know whether research has
been published previously.
• Journals should ask authors for a declaration that
the submitted work and its essential substance have
not previously been published and are not being
considered for publication elsewhere.
• If a primary research report is published and later
found to be redundant (i.e. has been published
before), the editor should contact the authors
and consider publishing a notice of redundant
publication.
• Editors have a right to demand original work and
to question authors about whether opinion pieces
(for example, editorials, letters, non-systematic
reviews) have been published before; journals should
establish a policy about how much overlap is consid-
ered acceptable between such publications.
• Journals that publish clinical trials should consider
making registration a requirement before publication
of such trials. Even if a journal does not make clin-
ical trial registration compulsory for publication, edi-
tors should encourage clear identiﬁcation of clinical
trials and should have a policy about where such
information is presented within the structure of the
published article.
• Papers that present new analyses or syntheses of
data that have already been published (for example,
sub-group analyses) should identify the primary data
source, including reference to the clinical trial regis-
tration number if one is available and full reference
to the related primary publications.
• See Box 5, Box 6.
• See Flowcharts 2a and b (pp. 16 and 17) ‘What to
do if you suspect redundant (duplicate) publication’
from Committee on Publication Ethics (COPE).
• Read Blackwell Publishing Copyright FAQs section
1.23 ‘What is the situation regarding dual publica-
tion?’ (2).
Box 1. Best Practice: Transparency
Sources of funding for research or publication
should always be disclosed. Editors should state
this directly in their editorial policy. Authors
should routinely include information about
research funding in all papers they prepare for
publication. Where a clinical trial registration
number is available, this should be included.
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acknowledgment
The International Committee of Medical Journal
Editors (ICMJE) provides a deﬁnition of author-
ship that is applicable beyond the medical sector
(1). Blackwell Publishing recommends that jour-
nal editors consider adopting the ICMJE author-
ship criteria as part of their editorial policy. The
ICMJE authorship criteria state ‘authorship credit
should be based on 1) substantial contributions
to conception and design, or acquisition of data,
or analysis and interpretation of data; 2) drafting
the article or revising it critically for important
intellectual content; and 3) ﬁnal approval of the
version to be published. Authors should meet
conditions 1, 2 and 3.’
Blackwell Publishing recommends that editors
ask authors to submit a short description of all
contributions to their manuscript. Each author’s
contribution should be described in brief.
Authors of research papers should state whether
they had complete access to the study data that
support the publication. Contributors who do
not qualify as authors should also be listed and
their particular contribution described. This
information should appear as an acknowledg-
ment.
Sample authorship description/acknowledgment
Drs A, B and C designed and conducted the study,
including patient recruitment, data collection, and
data analysis. Dr A prepared the manuscript draft
with important intellectual input from Drs B and
C. All authors approved the ﬁnal manuscript.
[Insert name of organization] provided funding for
the study, statistical support in analyzing the data
with input from Drs A, B and C, and also provided
funding for editorial support. Drs A, B and C had
complete access to the study data. We would like to
thank Dr D for her editorial support during prepar-
ation of this manuscript.
The Blackwell Publishing Exclusive License
Form, the OnlineOpen Form, or the Copyright
Assignment form, one of which must be submit-
ted before publication in any Blackwell journal,
requires the corresponding author to state that
written authorization for publication of the article
has been received by the corresponding author
from all co-authors.
Box 3. Best Practice: Collecting authorship
information
For research papers, authorship should be deci-
ded at the study launch. Policing authorship is
beyond the responsibilities of an editor. Editors
should demand transparent and complete
descriptions of who has contributed to a paper.
Editors should employ appropriate systems to
inform contributors about authorship criteria (if
used) and/or to obtain accurate information
about individuals’ contributions. Blackwell Pub-
lishing can advise Blackwell editors about how
best to do this, and the Blackwell Publishing elec-
tronic submission system can be used to explain
authorship criteria, and to collect and manage
authorship information efﬁciently.
Editors should ask authors to submit, as part
of their initial submission package, a statement
that all individuals listed as authors meet the
appropriate authorship criteria, that nobody who
qualiﬁes for authorship has been omitted from
the list, and that contributors and their funding
sources have been properly acknowledged, and
that authors and contributors have approved the
acknowledgment of their contribution.
Box 4. Best Practice: Attributing authorship
to a group
The International Committee of Medical Journal
Editors (ICMJE) provides guidance for instances
where a number of authors report on behalf of a
larger group of investigators (1). This guidance is
applicable outside the medical sector. Blackwell
Publishing recommends that editors adopt the
ICMJE policy. ICMJE guidance states: ‘When a
large, multi-center group has conducted the
work, the group should identify the individuals
who accept direct responsibility for the manu-
script. These individuals should fully meet the
criteria for authorship deﬁned above… When
submitting a group author manuscript, the cor-
responding author should clearly indicate the pre-
ferred citation and should clearly identify all
individual authors as well as the group name.’
The individual authors who accept direct respon-
sibility for the manuscript should list the mem-
bers of the larger authorship group in an
appendix to their acknowledgments.
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Research misconduct
If editors suspect research misconduct (for example,
data fabrication, falsiﬁcation or plagiarism), they
should attempt to ensure that this is properly investi-
gated by the appropriate authorities.
• Peer review sometimes reveals suspicion of miscon-
duct. Editors should inform peer reviewers about this
potential role.
• If peer reviewers raise concerns of serious miscon-
duct (for example, data fabrication, falsiﬁcation,
inappropriate image manipulation, or plagiarism),
these should be taken seriously. However, authors
have a right to respond to such allegations and for
investigations to be carried out with appropriate
speed and due diligence.
• Journals are not usually in a position to investigate
misconduct allegations themselves, but editors have a
responsibility to alert appropriate bodies (for exam-
ple, employers, funders, regulatory authorities) and
encourage them to investigate.
• Read more: The US Ofﬁce of Research Integrity Man-
aging Allegations of Scientiﬁc Misconduct: A Guidance
Document for Editors (4). Committee on Publication
Ethics Code of Conduct (5). UK Panel for Research
Integrity in Health and Biomedical Sciences (6).
• See Flowcharts 3a and b (pp. 18 and 19) ‘What to do
if you suspect fabricated data’ and Flowcharts 4a and b
(pp. 20 and 21) ‘What to do if you suspect plagiarism’
from Committee on Publication Ethics (COPE).
The Blackwell Publishing Exclusive License
Form, the OnlineOpen Form, or the Copyright
Assignment form, one of which must be submit-
ted before publication in any Blackwell journal,
requires signature from the corresponding author
to warrant that the article is an original work, has
not been published before and is not being con-
sidered for publication elsewhere in its ﬁnal form
either in printed or electronic form.
Some questions and answers about duplicate
publication
Q. ‘I am considering joining two of my fellow
journal editors in writing a joint editorial
about plagiarism and academic disputes. It
would be published simultaneously in three
journals.’
A. This is appropriate multiple publication.
Multiple publication helps convey the strength of
the (important) message. Each editorial should
refer to the others, as references and in a direct
statement.
Q. ‘We publish abstracts from specialist societies,
then often get the full paper a few months
later.’
A. This is not duplicate publication. Abstracts do
not present full results/analysis.
Q. ‘Our Chinese edition has translated papers
from the main journal a few months after the
original was published.’
A. This could be appropriate re-publication. Trans-
lated papers should make it clear (perhaps in
their titles) that they are translated from a
primary source, and they should refer directly to
the primary source (in their abstract and their
text, as a reference, and as a footnote).
Box 5. Best Practice: Redundant (multiple)
publication
Journal instructions should clearly explain what is,
and what is not, considered to be prior publication.
Abstracts and posters at conferences, results presen-
ted at meetings (for example, to inform investiga-
tors or participants about ﬁndings), results
databases (data without interpretation, discussion,
context or conclusions in the form of tables and text
to describe data/information where this is not easily
presented in tabular form) are not considered by
Blackwell Publishing to beprior publication.
Journals may choose to accept (i.e. consider
‘not redundant’) the re-publication of materials
that have been accurately translated from an ori-
ginal publication in a different language. Journals
that translate and publish material that has been
published elsewhere should ensure that they have
appropriate permission(s), should indicate clearly
that the material has been translated and re-pub-
lished, and should indicate clearly the original
source of the material. Editors may request copies
of related publications if they are concerned
about overlap and possible redundancy. Re-pub-
lishing in the same language as primary publica-
tion with the aim of serving different audiences is
more difﬁcult to justify when primary publication
is electronic and therefore easily accessible, but if
editors feel that this is appropriate they should
follow the same steps as for translation.
Editors should ensure that sub-group analyses,
meta- and secondary analyses are clearly identiﬁed
as analyses of data that have already been published,
that they refer directly to the primary source, and
that (if available) they include the clinical trial regis-
tration number fromthe primary publication.
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subjects
Editors should create publication policies that pro-
mote ethical and responsible research practices.
• Journal instructions should include links to rele-
vant frameworks such as the World Medical Associ-
ation Declaration of Helsinki for clinical trials (7).
• Editors should make clear the standards that they
require. Authors’ national standards for research prac-
tices (in human and animal studies) may be appropriate.
• Editors should seek assurances that studies have
been approved by relevant bodies (for example, insti-
tutional review board, research ethics committee,
data and safety monitoring board, regulatory author-
ities including those overseeing animal experiments).
• Editors should encourage peer reviewers to consi-
der ethical issues raised by the research they are
reviewing. Editors should request additional informa-
tion from authors if they feel this is required.
• See Box 7.
Where individual human subjects or case studies are
discussed (for example, as in medicine, psychology, cri-
minology), journals should protect conﬁdentiality and
should not permit publication of items that might upset
or harm participants/subjects, or breach conﬁdentiality
of, for example, the doctor–patient relationship.
• Journals should have policies about publishing
individual information and identiﬁable images from
patients/human subjects. The best policy is to require
explicit consent from any patients described in case
studies or shown in photographs.
• See Box 8.
Respecting cultures and heritage
Editors should exercise sensitivity when publishing
images of objects that might have cultural signiﬁ-
cance or cause offence (for example, Australian
aboriginal remains held in museums, religious texts,
historical events). It may be acceptable to publish
images of human remains (for example, Egyptian
mummies, Roman remains) so long as these consid-
erations are respected, despite the fact that for
archeological specimens it is impossible to obtain
consent from the individual or their descendants.
Informing readers about research and
publication misconduct
Editors should inform readers if ethical breaches
have occurred. Blackwell Publishing has published
general advice on publishing retractions.
• Journals should publish ‘retractions’ if work is pro-
ven to be fraudulent, or ‘expressions of concern’ if
editors have well-founded suspicions of misconduct.
Box 6. Best Practice: Registering clinical
trials
Since 2005, some medical journals [notably those
edited by members of the International Commit-
tee of Medical Journal Editors (ICMJE)] have
made registration in a publicly accessible trial
register a requirement for publishing clinical trials
(1). The World Health Organization (WHO), in
May 2006, urged ‘research institutions and com-
panies to register all medical studies that test
treatments on human beings’ (3). ICMJE allowed
authors a grace period for registration of new or
ongoing trials; this grace period ended September
2005. WHO states that ‘all clinical trials should
be registered at inception’, i.e. prospectively
before patients/subjects are enrolled, using the
complete 20 criteria described by its International
Clinical Trials Registry Platform (http://www.
who.int/ictrp/en/).
Blackwell Publishing recommends that editors
of medical journals require that the clinical tri-
als they consider for publication are registered
in free, public clinical trial registries (for example,
http://www.clinicaltrials.gov, http://clinicaltrials-
dev.ifpma.org/, http://isrctn.org/) before publica-
tion. Editors may choose to allow authors
submitting to their journals a grace period in
which ongoing or completed trials can be regis-
tered. Editors should develop policies about trial
registration that suit their own particular pub-
lishing environment, and should make their
policies about trial registration clear to prospect-
ive authors. Even if editors decide that prospect-
ive registration is not made compulsory for
their journal, journals should encourage clear
trial identiﬁcation and should have a policy for
including the clinical trial registration number
and name of the trial register within the
publication, and perhaps should adapt their
electronic submission process to collect this
information.
Sample wording for statement in instructions
for authors
[Insert journal name] requires that the clinical tri-
als submitted for its consideration are registered in
a publicly accessible database. Authors should
include the name of the trial register and their clin-
ical trial registration number at the end of their
abstract. If you wish the editor[s] to consider an
unregistered trial please explain brieﬂy why the trial
has not been registered.
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• Read Blackwell Publishing Copyright FAQs section
1.22 ‘What is the situation regarding retractions?’ (10).
Editorial standards and processes
Peer-review systems
Editors have a responsibility for ensuring the peer-
review process is fair and should aim to minimize bias.
• The merits of different peer-review systems (for
example, revealing peer reviewers’ identities to
authors and/or attempting to mask authors’ identi-
ties from peer reviewers) have been the subject of
considerable debate and study. Findings are contra-
dictory and there is no clear evidence of the superi-
ority of any one system over another. The beneﬁts
and feasibility of different systems probably vary
between disciplines. Editors should choose a peer-
review system that best suits their journal.
• Journals should have clearly set-out policies to
explain the type of peer review they use (for exam-
ple, blinded, non-blinded, multiple reviewers) and to
explain whether peer review varies between types of
article. Systems differ between journals (one system,
for example, would be to state that editorials and let-
ters are not peer reviewed, and that research articles
and review articles are always peer reviewed). Mater-
ial that has not been peer reviewed should be clearly
identiﬁed (for example, in a short description of dif-
ferent types of content in instructions for authors).
• Editors should apply consistent standards in their
peer-review processes.
• If discussions between an author, editor, and peer
reviewer have taken place in conﬁdence, they should
remain in conﬁdence unless explicit consent has been
given by all parties or there are exceptional circum-
stances (for example, when they might help substantiate
claims of intellectual property theft during peer review
– ‘Peer reviewer conduct and intellectual property’, p. 12).
• Editors or board members should never be
involved in editorial decisions about their own work.
Journals should have clearly set-out policies for
handling submissions from members of their editor-
ial board or employees. Some journals will not
consider original research papers from editors or
employees of the journal. Others have special proce-
dures for ensuring fair peer review in these instances.
Box 7. Best Practice: Protecting research
subjects, patients and experimental animals
Policing the standards of human or animal
research is beyond the responsibilities of an edi-
tor. Even so, medical journals can encourage
authors to follow the highest standards and may
consider requiring, for example, statements from
authors that trials conformed to Good Clinical
Practice [for example, US Food and Drug
Administration Good Clinical Practice in FDA-
Regulated Clinical Trials (8); UK Medicines
Research Council Guidelines for Good Clinical
Practice in Clinical Trials (9)] and/or the World
Medical Association Declaration of Helsinki (7).
Journals should ask authors to state that the
study they are submitting was approved by the
relevant research ethics committee or institutional
review board. If human participants were
involved, manuscripts must be accompanied by a
statement that the experiments were undertaken
with the understanding and appropriate informed
consent of each. If experimental animals were
used, the materials and methods (experimental
procedures) section must clearly indicate that
appropriate measures were taken to minimize
pain or discomfort, and details of animal care
should be provided. Blackwell Publishing suggests
that all these standards are deﬁned by the lead
investigator’s national standards.
Editors should reserve the right to reject papers
if there is doubt whether appropriate procedures
have been followed. If a paper has been submitted
from a country where there is no ethics commit-
tee, institutional review board, or similar review
and approval, editors should use their own
experience to judge whether the paper should be
published. If the decision is made to publish a
paper under these circumstances a short state-
ment should be included to explain the situation.
Box 8. Best Practice: Respecting
conﬁdentiality
In the majority of cases, editors should only con-
sider publishing information and images from
individual participants/subjects or patients where
the authors have obtained the individual’s explicit
consent. Exceptional cases may arise where gain-
ing the individual’s explicit consent is not poss-
ible but where publishing an individual’s
information or image can be demonstrated to
have a genuine public health interest. In cases like
this, before taking any action editors should seek
and follow council from the journal owner,
Blackwell Publishing and/or legal professionals.
In the case of technical images (for example,
radiographs, micrographs) editors should ensure
that all information that could identify the sub-
ject has been removed from the image.
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other editorial staff (including peer reviewers – see ‘Peer
reviewer selection and performance’, p. 12) should
withdraw from discussions about submissions where
any circumstances might prevent them offering unbi-
ased editorial decisions. See ‘Conﬂicts of interest’, p. 8.
• See Box 10.
• See Flowchart 5 (p. 22) ‘What to do if you suspect
an ethical problem with a submitted manuscript’
from Committee on Publication Ethics (COPE).
Peer reviewer selection and performance
Editors have a responsibility to ensure a high stand-
ard of objective, unbiased, and timely peer review.
• Editors should strive to establish and maintain a
database of suitably qualiﬁed peer reviewers.
• Editors should consider objectively monitoring the
performance of peer reviewers/editorial board mem-
bers and recording the quality and timeliness of their
reviews. Editors should ignore rude, defamatory peer
review. Peer reviewers who repeatedly produce poor
quality, tardy, abusive or unconstructive reviews
should not be used again.
• Editors should encourage peer reviewers to identify
if they have a conﬂict of interest with the material they
are being asked to review, and editors should ask that
peer reviewers decline invitations requesting peer review
where any circumstances might prevent them pro-
ducing fair peer review. See ‘Conﬂicts of interest’, p. 8.
• If authors request that an individual (or individu-
als) does not peer review their paper, editors should
use this information to inform their choice of peer
reviewer.
• Editors may choose to use peer reviewers suggested
by authors, but should not consider suggestions
made by authors as binding.
• Editors should request that peer reviewers who
delegate peer review to members of their staff inform
the editor when this occurs.
Box 9. Best Practice: Errata, Retractions,
Expressions of concern
Journals have a duty to publish corrections
(errata) when errors could affect the interpret-
ation of data or information, whatever the cause
of the error (i.e. arising from author errors or
from editorial mishaps). Likewise, journals should
publish ‘retractions’ if work is proven to be frau-
dulent, or ‘expressions of concern’ if editors have
well-founded suspicions of misconduct.
• The title of the erratum, retraction, or expres-
sion of concern should include the words ‘Erra-
tum’, ‘Retraction’, or ‘Expression of concern’.
• It should be published on a numbered page
(print and electronic) and should be listed in the
journal’s table of contents.
• It should cite the original article.
• It should enable the reader to identify and
understand the correction in context with the
errors made, or should explain why the article is
being retracted, or should explain the editor’s
concerns about the contents of the article.
• It should be linked electronically with the ori-
ginal electronic publication, wherever possible.
• It should be in a form that enables indexing
and abstracting services to identify and link
errata, retractions, and expressions of concern to
their original publications.
Box 10. Best Practice: Publishing work from
a journal’s own staff
When making editorial decisions about peer
reviewed articles where an editor is an author or is
acknowledged as a contributor, journals should
have mechanisms that ensure that the affected edi-
tors or staff members exclude themselves and are
not involved in the publication decision. In these
cases, a short statement explaining the process used
to make the editorial decision should be included.
When editors are presented with papers where their
own interests may impair their ability to make an
unbiased editorial decision, they should deputize
decisions about the paper to a suitably qualiﬁed
individual. See ‘Conﬂicts of interest’, p. 8.
Box 11. Best Practice: Timing of publication
Editors should aim to ensure timely peer review
and publication for papers they receive, especially
where, to the extent that this can be predicted,
ﬁndings may have important implications.
Authors should be aware that priority publication
is most likely for papers that, as judged by the
journal’s editorial staff, may have important
implications. The timing of publication may also
be inﬂuenced by themed issues or if editors
group submissions on a similar topic which, inev-
itably, prevents them from being published in the
order that articles were accepted. Online publica-
tion prior to print publication (Blackwell Publish-
ing OnlineEarly publication, or OnlineAccepted
publication) can provide the fastest route to pub-
lication and, therefore, to placing research (and
other) information in the public domain.
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• See ‘Peer reviewer conduct and intellectual prop-
erty’, p. 12.
• Read more: Ethics of Peer Review: A Guide for
Manuscript Reviewers, from the US Ofﬁce of
Research Integrity (ORI) by Yale University (11).
Appeals
Authors have a right to appeal editorial decisions.
• Journals should establish a mechanism for authors
to appeal peer review decisions. Explaining such a
system clearly in the journal’s instructions may bene-
ﬁt both authors and editors (for example, by dis-
couraging repeated or unfounded appeals).
• Editors should mediate all exchanges between
authors and peer reviewers during the peer-review
process (i.e. prior to publication). If agreement can-
not be reached, editors should consider inviting
comments from additional peer reviewer(s), if the
editor feels that this would be helpful. Journals
should consider stating in their guidelines that the
editor’s decision following such an appeal is ﬁnal.
• Journals should consider having a mechanism for
authors (and others) to comment on aspects of the
journal’s management.
• See Flowchart 6 (p. 23) ‘How to handle appeals’
and Flowchart 7 (p. 24) ‘What to do if someone
complains about your journal’.
Conﬂicts of interest
Editors, authors, and peer reviewers have a responsibil-
ity to disclose interests that might appear to affect their
ability to present or review data objectively. These
include relevant ﬁnancial (for example, patent owner-
ship, stock ownership, consultancies, speaker’s fees),
personal, political, intellectual, or religious interests.
‘Financial conﬂicts may be the easiest to identify
but they may not be the most inﬂuential.’ Horton
R. Lancet (12).
‘We want to try to have a policy that covers all
conﬂicts of interest. Other sources of conﬂict are
personal, political, academic, and religious, and we
believe that these may be just as potent as ﬁnancial
conﬂicts.’ Smith R. BMJ (13).
• Editors and board members should, whenever these
are relevant to the content being considered or pub-
lished, declare their interests and afﬁliations.
• Editors should seek disclosure statements from all
authors and peer reviewers and should clearly explain
the types of conﬂicts of interest that should be dis-
closed. Authors’ conﬂicts of interest (or information
describing the absence of conﬂicts of interest) should
be published whenever these are directly or indirectly
relevant to the content being published and when-
ever they are signiﬁcant. For example, owning
USD10 stock in a company that manufactures a pro-
duct discussed in an article would not be signiﬁcant,
whereas consultancy fees of USD10,000 annually or
the equivalent of 5% of an author’s gross income
from the previous year could be considered signiﬁ-
cant. Editors may consider not publishing details of
authors’ interests when these interests have no rele-
vance to the content being published. If there is
doubt about whether conﬂicts are relevant or signiﬁ-
cant, it is prudent to disclose.
• The existence of a conﬂict of interest (for example,
employment with a research funder) should not pre-
vent someone from being listed as an author if they
qualify for authorship. Editors may prefer not to
commission subjective articles (for example, editorials
or non-systematic reviews) from authors with con-
ﬂicts of interest. However, arguments can be made
that such authors are often well informed and have
interesting opinions. Strict policies preventing people
with conﬂicts of interest from publishing opinion
pieces may encourage authors to conceal relevant
interests, and may therefore be counter-productive.
• Readers will beneﬁt from transparency, including
knowing authors’ and contributors’ afﬁliations and
interests. Editors should strive to maintain transpar-
ent policies and procedures regarding authorship and
disclosure of conﬂicts of interest.
• See ‘Transparency’, p. 1.
• See Box 12.
• See Flowchart 8 (p. 25) ‘What to do if a reviewer sus-
pects undisclosed conﬂict of interest in a submitted
manuscript’, Flowchart 9 (p. 26) ‘What to do if a reader
suspects undisclosed conﬂict of interest in a published
article’, and Flowchart 5 (p. 22) ‘What to do if you sus-
pect an ethical problem with a submitted manuscript’
from Committee on Publication Ethics (COPE).
Editorial independence
Editorial independence should be respected. Journal
owners (both learned societies and publishers) should
not interfere with editorial decisions. The relationship
between the editor and the journal owner and pub-
lisher should be set out in a formal contract and an
appeal mechanism for disputes should be established.
• Decisions by editors about whether to publish indi-
vidual items submitted to a journal should not be
inﬂuenced by pressure from the editor’s employer,
the journal owner or the publisher. Ideally, the prin-
ciples of editorial independence should be set out in
the editor’s contract. Editors’ contracts at Blackwell
Publishing describe the principles of editorial inde-
pendence.
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Editors should adopt a policy about conﬂicts of
interest that best suits their particular publishing
environment, and should describe this in their
editorial policy. Editors should adapt their sub-
mission processes to encourage submission by
authors of the required information. For example,
Blackwell Publishing can conﬁgure a journal’s
online submission system to identify submissions
without required information, and can return
these submissions to authors with an explanation
that their submission cannot be processed with-
out completed information.
Editors should require statements about con-
ﬂicts of interest from authors. Editors should
explain that these statements should provide
information about ﬁnancial (for example, patent
ownership, stock ownership, consultancies, spea-
ker’s fees), personal, political, intellectual, or
religious interests relevant to the area of research
or discussion. Research or publication funding is
considered separately (see ‘Who funded the
work?’, p. 1).
Editors should describe the detail that they
require from conﬂict of interest statements,
including the period that these statements should
cover (3 years is suggested, but relevant conﬂicts
of interest that are older should not be neglec-
ted). When describing ﬁnancial information, the
purpose of the funding received should be des-
cribed by funding organization (for example, tra-
vel grant and speaker’s fees received from [name
of organization]). Editors could consider using
bands (for example, per year, bands for ﬁnancial
disclosures of <USD10,000 and >USD10,000 or
the equivalent of <5% and >5% of an author’s
gross income from the previous year) for authors
to describe the level of relevant funding and from
which organizations this has been received, or
to describe the amount of relevant stocks and
shares that they own (not including stocks and
shares owned as part of a general, non-speciﬁc
portfolio).
Blackwell Publishing recommends that editors
publish the minimum amount of information
that will provide context and transparency for
readers: the sources and types of funding received
by the authors. Editors should always publish a
statement to describe authors’ conﬂicts of interest
or, alternatively, a statement that conﬁrms the
absence of conﬂicts of interest. If there is doubt
about whether conﬂicts are relevant, it is prudent
to disclose. Authors should routinely provide a
statement of conﬂicts of interest (or lack thereof),
whether or not a journal requests this statement.
Sample wording
[Name of individual] has received fees for serving
as a speaker, a consultant and an advisory board
member for [names of organizations], and has
received research funding from [names of organiza-
tion]. [Name of individual] is an employee of
[name of organization]. [Name of individual] owns
stocks and shares in [name of organization].
[Name of individual] owns patent [patent identiﬁ-
cation and brief description].
It is good practice for journal editors, board
members and staff (if involved with decisions
about publication) to make and regularly update
disclosures (either in the journal or via its web-
site) about their relevant interests.
Box 13. Best Practice: Commercial issues
Blackwell Publishing does not allow its sales
teams to become involved with the editorial
decision making process.
The extent of the editorial information avail-
able to the sales team and the timing of its disclo-
sure to them will be agreed for each journal with
the relevant academic society partners and journal
editors. Sales teams may only use this informa-
tion after editorial decisions are ﬁnalized, to
provide accurate and timely information to their
potential customers. The positions available for
advertising in a journal (for example, within or
adjacent to an article, or collected in ‘wells’
within the journal) will be agreed for each
journal with the relevant academic society part-
ners and journal editors. Whether it is permiss-
ible to sell reprints of OnlineEarly papers (i.e.
papers published online prior to print publica-
tion) will be agreed for each journal with the
relevant academic society partners and journal
editors.
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discuss general editorial processes and policies with
journal editors (for example, whether or not a jour-
nal should publish a particular type of article), but
they should not get involved in decisions made by
the editor about individual articles.
• See Box 13.
• Read more: Relations between Editors and their
Publishing or Sponsoring Societies from the Council
of Science Editors (CSE) (14).
Editors, journal owners, and publishers should estab-
lish processes that minimize the risk of editorial
decisions being inﬂuenced by commercial, academic,
personal or political factors.
• It is often impossible to completely insulate edi-
torial decisions from issues that may inﬂuence
them, such as commercial considerations. For
example, editors will know which articles are likely
to attract offprint or reprint sales, but they should
judge all submissions on their scientiﬁc merit and
minimize the inﬂuence of other factors. If journals
publish advertisements, the sale of advertising must
be handled separately from editorial processes.
• Journals that publish special issues, supplements
or sections (or similar material) funded by third-
party organisations should establish policies for
how these are handled. The funding organization
(the supporter or sometimes sponsor) should not
be allowed to inﬂuence the selection or editing of
submissions, and all funded items should be clearly
identiﬁed.
• All funded material should meet the aims and
purposes of the journal carrying the material.
• See Box 14.
Accuracy
Journal editors have a responsibility to ensure the
accuracy of the material they publish.
• Journals should encourage authors and readers to
inform them if they discover errors in published
work.
• Editors should publish corrections if errors are dis-
covered that could affect the interpretation of data
or information presented in an article.
• Corrections arising from errors within an article
(by authors or journals) should be distinguishable
from retractions and statements of concern relating
to misconduct (see ‘Informing readers about research
and publication misconduct’, p. 5).
• Corrections should be included in indexing sys-
tems and linked to the original article wherever
possible.
• See Box 9.
Box 14. Best Practice: Supplements and
other funded publications
Journals may choose to publish supplements, spe-
cial issues, sections, or similar materials that are
funded by a third-party organization, for exam-
ple, a company, society or charity (the supporter
or sometimes sponsor). The content of funded
items must align with the purpose of the journal.
Journals should consider describing their policy
for funded items, should always present readers
with the name(s) of the organization(s) funding
the publication, and should consider making
statements at the beginning and at relevant points
within the funded item, including:
• Explicit declaration of conﬂicts of interest or
absence thereof for all contributions, including
those of both authors and editors (see ‘Conﬂicts
of interest’, p. 8).
• Explicit acknowledgment to any contributions
(for example, editorial assistance) made by any-
one other than named authors, including their
afﬁliations (see ‘Who did the work?’, p. 2).
• Description of the processes used to select, review
and edit the content, especially the differences in
this process, if there are any, from the journal’s nor-
mal content selection and peer-review processes.
• Details of the journal’s afﬁliations and Editorial
Board.
Blackwell Publishing recommends that journals
appoint co-editors (including the individual who
proposed the initial idea for the funded material
and a second individual appointed by the journal)
as standard procedure for all funded materials.
This enables editorial decisions to be easily depu-
tized as should be the case when one editor is an
author or is acknowledged as a contributor to a
particular article, or when one editor is presented
with papers where their own interests may impair
their ability to make an unbiased editorial decision.
A short statement explaining the process used to
make editorial decisions should be included.
Journals should not permit funding organizations
to make decisions beyond those about which publi-
cations they choose to fund and the extent of the
funding. Decisions about the selection of authors
and about the selection and editing of contents to be
presented in funded publications should be made by
the editor (or co-editors) of the funded publication.
Blackwell Publishing reserves the right not to pub-
lish any funded publication that does not comply with
the requirements deﬁned for the journal to which the
manuscript or supplement has been submitted.
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Journals should encourage academic debate.
• Journals should encourage correspondence com-
menting on published items and should always invite
authors to respond to any correspondence before
publication. However, authors do not have a right to
veto unfavorable comments about their work and
they may choose not to respond to criticisms.
• Neither peer-reviewer comments nor published
correspondence should contain personal attacks on
the authors. Editors should encourage peer reviewers
to criticize the work not the researcher and should
edit (or reject) letters containing personal or offen-
sive statements.
Responsible publication practices
Editors should pursue cases of suspected misconduct
that become apparent during the peer-review and
publication processes, to the extent and in the
ways deﬁned in this document in the ‘Promoting
research integrity’ section (p. 4). Editors should ﬁrst
work with the authors, the journal owners and/or
the journal publishers (at Blackwell Publishing this is
via the Journal Publishing Manager), referring to
information from the Committee on Publication
Ethics (COPE), the Council of Science Editors
(CSE), or another appropriate body if further advice
is needed.
• In instances of conﬁrmed misconduct, editors may
consider imposing sanctions on the authors at fault
for a period of time. Sanctions must be applied con-
sistently. Before imposing sanctions, editors should
formally deﬁne the conditions in which they will
apply (and remove) sanctions, and the processes they
will use to do this. Editors of Blackwell journals are
encouraged to consult Blackwell Publishing if consid-
ering sanctions to ensure that the appropriate pro-
cesses are applied.
• A body such as the Committee on Publication Eth-
ics (COPE) can provide editors with impartial advice
from other editors about difﬁcult cases, provide
information about the prevalence of various types of
misconduct and other ethical issues, and allow edi-
tors to learn from other journals’ experiences by ref-
erence to previous cases.
• Read more: reported cases of publication miscon-
duct and advice from COPE (15).
Journals should promote responsible publication
practices in their instructions for authors.
• Read more: Committee on Publication Ethics
guidelines on publication practice (5); International
Committee of Medical Journal Editors Uniform
Requirements (1); Council of Science Editors (CSE)
white paper (14); World Association of Medical Edi-
tors policy statements (16); Good Publication Prac-
tice for pharmaceutical companies (17); American
Medical Writers Association Code of Ethics (18);
European Medical Writers Association (EMWA)
guidelines on the role of medical writers in the
development of peer-reviewed publications (19);
American Statistical Association (ASA) Comprehen-
sive Ethical Guidelines for Statistical Practice (20);
American Chemical Society (ACS) Ethical Guidelines
(21); American Psychological Association Ethical
Principles of Psychologists and Code of Conduct,
Section 8 ‘Research and Publication’ (22); Consolid-
ated Standards of Reporting Trials (CONSORT)
(23); Standards for Reporting of Diagnostic Accuracy
(STARD) (24).
Blackwell Publishing has published general advice on
misconduct and the available sanctions (including
plagiarism, dealing with research misconduct, and
irregularities within the content of an article, inclu-
ding dual publication, libel, slander and obscenity).
• Read Blackwell Publishing Copyright FAQs, partic-
ularly sections 1.21 [plagiarism (25)], 1.23 [dual pub-
lication (2)], 1.24 [libel, slander and obscenity (26)].
• See Flowchart 5 (p. 22) ‘What to do if you suspect
an ethical problem with a submitted manuscript’
from Committee on Publication Ethics (COPE).
Ownership of ideas and expression
Plagiarism and copyright
Journal editors and readers have a right to expect
that submitted work is the author’s own, that it has
not been plagiarized (i.e. taken from other authors
without permission, if permission is required) and
that copyright has not been breached (for example, if
ﬁgures or tables are reproduced).
• Many journals require authors to declare that the
work reported is their own and that they are the
copyright owner (or else have obtained the copyright
owner’s permission). This is enforced further by the
Blackwell Publishing Exclusive License Form, the On-
lineOpen Form, or the Copyright Assignment form,
one of which must be submitted before publication
in any Blackwell journal. This form requires signa-
ture from the corresponding author to warrant that
the article is an original work, has not been pub-
lished before and is not being considered for publica-
tion elsewhere in its ﬁnal form either in printed or
electronic form.
• See ‘Transparency’ (p. 1) and ‘Promoting research
integrity’ (p. 4).
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Journal owners and authors have a right to protect
their intellectual property.
• Different systems are available to protect intellec-
tual property and journals must choose whichever
best suits their purpose and ethos. Some Blackwell
journals require authors to relinquish their copyright,
other Blackwell journals license content from
authors, whereas others adopt an open-access model
under creative commons licenses. Blackwell Publish-
ing recommends adoption of a system that licenses
content from authors, rather than more traditional
systems that require copyright assignment/transfer by
authors.
• See Box 15.
• Read more: Blackwell Publishing Copyright FAQs
(27).
Peer reviewer conduct and intellectual
property
Authors are entitled to expect that peer reviewers or
other individuals privy to the work an author sub-
mits to a journal will not steal their research ideas or
plagiarize their work.
• Journal guidelines to peer reviewers should be
explicit about the roles and responsibilities of peer
reviewers, in particular the need to treat submitted
material in conﬁdence until it has been published.
• Journals should ask peer reviewers to destroy sub-
mitted manuscripts after they have reviewed them.
• Editors should expect allegations of theft or pla-
giarism to be substantiated, and should treat allega-
tions of theft or plagiarism seriously.
• Editors should protect peer reviewers from authors
and, even if peer reviewer identities are revealed,
should discourage authors from contacting peer re-
viewers directly, especially if misconduct is suspected.
• See ‘Promoting research integrity’, p. 4.
• Read more: Ethics of Peer Review: A Guide for
Manuscript Reviewers, from the US Ofﬁce of
Research Integrity (ORI) by Yale University (11).
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Changes in authorship
(a)   Corresponding author requests addition of extra author before publication
Clarify reason for change in authorship
Check that all authors consent to addition of
extra author
Amend contributor details (role of
each contributor/author) if included
Proceed with
review/publication
All authors agree Authors do not agree
Suspend review/publication of paper until
authorship has been agreed by all
authors, if necessary, via institution(s)
Get new author to complete
journal’s authorship
declaration (if used)
Note:  major changes in
response to reviewer
comments, e.g. adding new
data might justify the inclusion
of a new author
Appendix. Flowcharts
Flowchart 1a from Committee on Publication Ethics (COPE).
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Changes in authorship
(c)   Request for addition of extra author after publication
Clarify reason for change in authorship
Check that all authors consent to addition of
extra author
Publish correction if required by
institution(s)
All authors agree Authors do not agree
Publish correction if needed
To prevent future problems:
(1) Before publication, get
authors to sign statement that
all listed authors meet
authorship criteria and that no
others meeting the criteria have
been omitted
(2) Publish details of each
person’s contribution to the
research and publication
Publish correction
All authors agree Authors still cannot agree
Explain that you will not change the
authorship until you have written
agreement from all authors
Provide authorship guidelines but do not
enter into dispute
Refer case to authors’
institution(s) and ask it/them to
adjudicate
Ask why author was omitted from
original list – ideally, refer to
journal guidelines or authorship
declaration which should state
that all authors meet appropriate
criteria and that no deserving
authors have been omitted
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Changes in authorship
(b)   Corresponding author requests removal of  author before publication
Clarify reason for change in authorship
Check that all authors consent to removal of author
Proceed with
review/publication
All authors agree Authors do not agree
Suspend review/publication of paper until
authorship has been agreed
Inform excluded author(s) that if they
wish to pursue the matter they should do
this with their co-authors or institutions
rather than the editor
Amend author list and contributor
details (role of each contributor/author)/
acknowledgements as required
Most important to check
with the author(s) whose
name(s) is/are being
removed from the paper
and get their agreement in 
writing
Flowchart 1b and c from Committee on Publication Ethics (COPE).
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Changes in authorship
(d)  Request for removal of author after publication
Clarify reason for change in authorship







not wish to respond













Author(s) writes a letter Author(s) does not agree to
write letter (or writes
something unpublishable)
If author insists on




Suggest author(s) put views in a letter
and explain you will give other authors a
chance to respond and will publish both
letters if suitable (i.e. correct length,
not libellous)
Ask why author wishes to be
removed from list – refer to
journal guidelines or authorship
declaration which should state
that all authors meet appropriate
criteria. Ask if author suspects
fraud/misconduct
Flowchart 1d from Committee on Publication Ethics (COPE).
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What to do if you suspect redundant (duplicate) publication
(a)   Suspected redundant publication in a submitted manuscript
Reviewer informs editor about redundant publication
Thank reviewer and say you plan to investigate
Get full documentary evidence if not already provided
Check degree of overlap/redundancy





























Write to author (all authors if
possible) rejecting submission,
explaining position and expected
future behavior
Contact author’s institution requesting your concern is
passed to author’s superior and/or person 
responsible for research governance
Try to obtain acknowledgment of your letter
 
Write to author (all authors if
possible) rejecting submission,
explaining position and expected
future behavior
Major overlap/redundancy (i.e. based on
same data with identical or very similar
findings and/or
evidence authors have sought to hide
redundancy e.g. by changing title or
author order or not citing previous papers)
Minor overlap with some element




Note: The instructions to authors
should state the journal’s policy on
redundant publication
Asking authors to sign a statement












Explain that secondary papers must
refer to original
Request missing reference to original
and/or remove overlapping material
Proceed with review
Contact corresponding author in
writing, ideally enclosing signed
authorship statement (or cover
letter) stating that submitted work
has not been published elsewhere






Flowchart 2a from Committee on Publication Ethics (COPE).
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What to do if you suspect redundant (duplicate) publication
(b)   Suspected redundant publication in a published article
Reader informs editor about redundant publication
Thank reader and say you plan to investigate
Get full documentary evidence if not already provided
Check degree of overlap/redundancy































of redundant publication or
retraction
Inform editor of other journal
involved
Contact author’s institution requesting your concern is
passed to author’s superior and/or person 
responsible for research governance
Write to author (all authors if
possible) explaining position
and expected future behavior
Major overlap/redundancy (i.e. based on
same dataset with identical findings
and/or evidence that authors
have sought to hide redundancy,
e.g. by changing title or author order
or not referring to previous papers)
Minor overlap (”salami publishing”
with some element of redundancy)
or legitimate re-analysis (e.g. sub-
group/extended follow-up/discussion
aimed at different audience)
Note: The instructions to authors
should state the journal’s policy on
redundant publication
Asking authors to sign a statement
or tick a box may be helpful in
subsequent investigations
Contact author in neutral
terms/expressing disappointment/
explaining journal’s position
Explain that secondary papers must
refer to original
Discuss publishing correction giving
reference to original paper
Where editor has reason to believe
failure to refer to previous paper(s)
was deliberate, consider informing
author’s superior or person
responsible for research governance
Contact corresponding author in
writing, ideally enclosing signed
authorship statement (or cover
letter) stating that submitted work
has not been published elsewhere













Flowchart 2b from Committee on Publication Ethics (COPE).
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What to do if you suspect fabricated data
(a)   Suspected fabricated data in a submitted manuscript
Reviewer expresses suspicion of fabricated data
Thank reviewer, ask for evidence (if not already
provided) and state your plans to investigate
Consider getting a 2nd opinion from another reviewer






















Attempt to contact all other
authors (check
Medline/Google for emails)




Contact author’s institution requesting your concern is
passed to author’s superior and/or person responsible
for research governance, if necessary coordinating with
co-authors’ institutions 
 
If raw data are supplied
these should be
assessed by a suitably
qualified person,
ideally in cooperation
with the author’s 
institution
Contact author to explain concerns but
do not make direct accusation
Request raw data/lab
notebooks as appropriate
Apologize to author, proceed




(e.g. GMC for UK doctors)
requesting an enquiry
Inform all authors
that you intend to
contact institution/
regulatory body
Flowchart 3a from Committee on Publication Ethics (COPE).
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What to do if you suspect fabricated data
(b)   Suspected fabricated data in a published article
Reader expresses suspicion of fabricated data
Thank reader and state your plans to investigate
Consider getting a 2nd opinion from another reviewer



























Publish correction if necessary
(e.g. if an honest error has
been detected)
Inform reader of outcome
Contact author’s institution requesting your concern is
passed to author’s superior and/or person responsible
for research governance, if necessary coordinating
with co-authors’ institutions 
 
If raw data are supplied these
should be assessed by a
suitably qualified person,
ideally in cooperation with the
author’s institution
Contact author to explain your concerns






(e.g. GMC for UK doctors)
requesting an enquiry
Inform all authors




Flowchart 3b from Committee on Publication Ethics (COPE).
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What to do if you suspect plagiarism
(a)   Suspected plagiarism in a submitted manuscript
Reviewer informs editor about suspected plagiarism
Thank reviewer and say you plan to investigate
Get full documentary evidence if not already provided
Check degree of copying












If no response, keep
contacting institution
every 3–6 months
If no resolution, consider
contacting other
authorities, e.g. ORI in





















Write to author (all authors if
possible) rejecting submission,
explaining position and expected
future behavior
Contact author’s institution requesting your concern is
passed to author’s superior and/or person
responsible for research governance
  
Write to author (all authors if possible)
rejecting submission or requesting
revision, explaining position and
expected future behavior
Clear plagiarism (unattributed
use of large portions of text
and/or data, presented as if
they were by the plagiarist)
Minor copying of short phrases
only (e.g. in discussion of
research paper from non-
native language speaker)
No misattribution of data
Note: The instructions to authors
should include a definition of
plagiarism and state the
journal’s policy on it




Ask author to rephrase copied
phrases or include as direct
quotations with references
Proceed with review
Contact corresponding author in
writing, ideally enclosing signed
authorship statement (or cover
letter) stating that submitted work
is original/the author’s own and
documentary evidence of plagiarism
Flowchart 4a from Committee on Publication Ethics (COPE).
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What to do if you suspect plagiarism
(b)   Suspected plagiarism in a published article
Reader informs editor about suspected plagiarism
Thank reader and say you plan to investigate
Get full documentary evidence if not already provided
Check degree of copying













If no response, keep
contacting institution
every 3–6 months
If no resolution, consider
contacting other
authorities, e.g. ORI in



















Inform editor of other journal(s)
involved or publisher of
plagiarized books
Contact author’s institution requesting your concern is
passed to author’s superior and/or person
responsible for research governance
 
Write to author (all authors if
possible) explaining position
and expected future behavior
Clear plagiarism (unattributed
use of large portions of text
and/or data, presented as if they
were by the plagiarist)
Minor copying of short phrases
only (e.g. in discussion of
research paper)
No misattribution of data
Inform reader (and plagiarized
author(s) if different) of
journal’s actions
Note: The instructions to authors
should include a definition of
plagiarism and state the journal’s
policy on it





giving reference to original
paper(s) if this has been omitted
Contact corresponding author in
writing, ideally enclosing signed
authorship statement (or cover
letter) stating that work is
original/the author’s own and
documentary evidence of
plagiarism
Flowchart 4b from Committee on Publication Ethics (COPE).
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What to do if you suspect an ethical problem with a submitted manuscript
Thank reviewer and say you plan to investigate
Forward concerns to author’s
employer or person responsible




e.g. lack of ethical approval/concern re
patient consent or protection/concern
re animal experimentation
e.g. request evidence of ethical
committee/IRB approval/copy of
informed consent documents







Inform author that review
process is suspended until
case is resolved
Consider submitting case
to COPE if it raises novel
ethical issues









Refer to other authorities
(e.g. medical registration
body, UKPRI, ORI)
Satisfactory answer Unsatisfactory answer/no response
Flowchart 5 from Committee on Publication Ethics (COPE).
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If reviewers gave conflicting advice,

















Inform author of decision
Explain that this decision is final
Inform author of action
Reject appeal
Author appeals Author appeals
*Decision making process
(e.g. editorial board, committee)
will depend on journal
Flowchart 6 from Blackwell Publishing.
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complaints will depend on the
journal’s structure and the
editor’s contract
What to do if someone complains about your journal
Journal receives complaint









Acknowledge receipt and explain
complaints procedure
Editor attempts to resolve
issue/apologizes/provides explanation
Editor refers complaint to, for example*:
- publications committee




case to COPE or other
body, e.g. Press
Complaints Commission
Note: to ensure correct
handling of complaints,
editors should ensure that
their journal has an
agreed procedure and
that this is set out in their
contract
See flowchart for how
COPE handles complaints
Flowchart 7 from Blackwell Publishing.
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What to do if a reviewer suspects undisclosed conflict of interest (Col) in a submitted manuscript
Reviewer informs editor of author’s undisclosed Col
Thank reviewer and say you plan to investigate
Contact author(s) and express concern
Proceed with review/publication
Inform reviewer of outcome
Explain journal policy/Col definition
clearly and obtain signed statement from
author(s) about all relevant Cols







To avoid future problems:
Always get signed statement
of Cols from all authors
before publication (or get
them to tick a box if they
declare no conflict)
Ensure journal guidelines
include clear definition of Col
Flowchart 8 from Committee on Publication Ethics (COPE).
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What to do if a reader suspects undisclosed conflict of interest (Col) in a published article
Reader informs editor of author’s undisclosed Col
Thank reader and say you plan to investigate
Contact author(s) and express concern
Inform reader of outcome
Explain journal policy/Col definition
clearly and obtain signed statement from
author(s) about all relevant Cols
(if not obtained previously)
Thank author but point out
seriousness of omission
Publish correction to competing




To avoid future problems:
Always get signed statement
of Cols from all authors and
reviewers before publication
Ensure journal guidelines
include clear definition of Col
It may be helpful to provide a
copy of the journal’s
policy/definition of Col
Flowchart 9 from Committee on Publication Ethics (COPE).
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